- Home
- EVC vs GNLX Comparison
EVC vs GNLX Comparison
Compare EVC & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVC
- GNLX
- Stock Information
- Founded
- EVC 1996
- GNLX 2001
- Country
- EVC United States
- GNLX United States
- Employees
- EVC N/A
- GNLX N/A
- Industry
- EVC Broadcasting
- GNLX Biotechnology: Pharmaceutical Preparations
- Sector
- EVC Industrials
- GNLX Health Care
- Exchange
- EVC Nasdaq
- GNLX Nasdaq
- Market Cap
- EVC 171.0M
- GNLX 94.0M
- IPO Year
- EVC 2000
- GNLX 2023
- Fundamental
- Price
- EVC $2.07
- GNLX $2.42
- Analyst Decision
- EVC
- GNLX Strong Buy
- Analyst Count
- EVC 0
- GNLX 4
- Target Price
- EVC N/A
- GNLX $17.75
- AVG Volume (30 Days)
- EVC 185.0K
- GNLX 159.0K
- Earning Date
- EVC 05-08-2025
- GNLX 05-06-2025
- Dividend Yield
- EVC 9.66%
- GNLX N/A
- EPS Growth
- EVC N/A
- GNLX N/A
- EPS
- EVC N/A
- GNLX N/A
- Revenue
- EVC $378,623,000.00
- GNLX N/A
- Revenue This Year
- EVC $64.06
- GNLX N/A
- Revenue Next Year
- EVC N/A
- GNLX N/A
- P/E Ratio
- EVC N/A
- GNLX N/A
- Revenue Growth
- EVC 23.10
- GNLX N/A
- 52 Week Low
- EVC $1.58
- GNLX $1.60
- 52 Week High
- EVC $2.73
- GNLX $5.89
- Technical
- Relative Strength Index (RSI)
- EVC 62.90
- GNLX 43.88
- Support Level
- EVC $1.85
- GNLX $2.42
- Resistance Level
- EVC $2.04
- GNLX $2.78
- Average True Range (ATR)
- EVC 0.08
- GNLX 0.24
- MACD
- EVC 0.02
- GNLX 0.00
- Stochastic Oscillator
- EVC 86.67
- GNLX 11.43
About EVC Entravision Communications Corporation
Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the Media segment. Geographically, the company generates the majority of its revenue from the United States.
About GNLX Genelux Corporation
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.